Conversion of enediynes into quinones by antibody catalysis and in aqueous buffers: implications for an alternative enediyne therapeutic mechanism.
Jones
L H
LH
Harwig
C W
CW
Wentworth
P
P
Simeonov
A
A
Wentworth
A D
AD
Py
S
S
Ashley
J A
JA
Lerner
R A
RA
Janda
K D
KD
D017151:Antibodies, Catalytic / Q000378:metabolism*; D002021:Buffers; D002384:Catalysis; D053281:Enediynes; D011743:Pyrimidines / Q000737:chemistry*; D011809:Quinones / Q000138:chemical synthesis* / Q000737:chemistry; D017366:Serotonin Receptor Agonists / Q000138:chemical synthesis / Q000737:chemistry; D013764:Tetrahydronaphthalenes / Q000138:chemical synthesis / Q000737:chemistry
D017151:Antibodies, Catalytic; D002021:Buffers; D053281:Enediynes; D011743:Pyrimidines; D011809:Quinones; D017366:Serotonin Receptor Agonists; D013764:Tetrahydronaphthalenes; C418566:enediynol; C095210:tetralin